South African cassava mosaic virus (SACMV) genome structure and the effect of SACMV on cassava leaf symptoms. by Bulelani L. Sizani (21485746)

Subjects:

Transcript levels of MAPK, NIK, NLR and SA-dependent gene pathways and responsive genes. by Bulelani L. Sizani (21485746)

Subjects:

Differentially-expressed NLR genes in susceptible T200 and tolerant TME3 genotypes infected with SACMV. by Bulelani L. Sizani (21485746)

Subjects:

Total count of HiFi reads indicating gene variation in 24 cassava genotypes. by Bulelani L. Sizani (21485746)

Subjects:

Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR). by Bulelani L. Sizani (21485746)

Subjects:

Characteristics of HACE respondents by year. by David Henderson (4612354)

Subjects:

Details of the GWAS data in this study. by Jing Wang (6206297)

Subjects:

Restoration of <i>S</i>. Paratyphi A L O-ag reduces VL O-ag production and impacts IgM binding. by Fermin E. Guerra (6084545)

Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

Subjects:

Group control-after intervention. by Nan Tang (642590)

Subjects:

Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Group control-before intervention. by Nan Tang (642590)

Subjects:

Patient satisfaction with SFA intervention(%). by Nan Tang (642590)

Subjects:

Pre-Experiment. by Nan Tang (642590)

Subjects:

Group SFA-after intervention. by Nan Tang (642590)

Subjects:

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…Yellow indicates an increase in time-frequency clusters during number trials versus inter-trial intervals while blue indicates a decrease in time-frequency clusters. …”

Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

“…<p>(A) O-ag modifications by glycosyltransferases in <i>S.</i> Paratyphi A decrease complement activation as measured by C5a release and (B) IgM binding. …”

O-ag length and composition impacts complement activation by <i>Salmonella</i> nontyphoidal and enteric fever serovars. by Fermin E. Guerra (6084545)

<i>S</i>. Paratyphi A has deficient L O-ag production due to R98C mutation in WzzB. by Fermin E. Guerra (6084545)